Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Chronic venous disease and venous hypertension are common consequences of valve insufficiency, yet the molecular mechanisms regulating the formation and maintenance of venous valves have not been studied. Here, we provide what we believe to be the first description of venous valve morphogenesis and identify signaling pathways required for the process. The initial stages of valve development were found to involve induction of ephrin-B2, a key marker of arterial identity, by venous endothelial cells. Intriguingly, developing and mature venous valves also expressed a repertoire of proteins, including prospero-related homeobox 1 (Prox1), Vegfr3, and integrin-α9, previously characterized as specific and critical regulators of lymphangiogenesis. Using global and venous valve-selective knockout mice, we further demonstrate the requirement of ephrin-B2 and integrin-α9 signaling for the development and maintenance of venous valves. Our findings therefore identified molecular regulators of venous valve development and maintenance and highlighted the involvement of common morphogenetic processes and signaling pathways in controlling valve formation in veins and lymphatic vessels. Unexpectedly, we found that venous valve endothelial cells closely resemble lymphatic (valve) endothelia at the molecular level, suggesting plasticity in the ability of a terminally differentiated endothelial cell to take on a different phenotypic identity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,441
Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology
Davies, P. F. (2009) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1397 · Cited by 1,209
Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W., & Klein, R. (1999) · Genes & Development · doi:10.1101/gad.13.3.295 · Cited by 1,025
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
Wigle, J. T., Harvey, N., Detmar, M., Lagutina, I., Grosveld, G., Gunn, M. D., Jackson, D. G., & Oliver, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1505 · Cited by 943 · cited 2×
“In particular, expression of Prox1 in venous valves is surprising, given its well-established role as the master regulator of lymphatic endothelial cell fate (24, 28).”
BackgroundCardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813
Heart Valve Development: Endothelial Cell Signaling and Differentiation
Armstrong, E. J., & Bischoff, J. (2004) · Circulation Research · doi:10.1161/01.res.0000141146.95728.da · Cited by 647
Fang, J., Dagenais, S. L., Erickson, R. P., Arlt, M. F., Glynn, M. W., Gorski, J. L., Seaver, L. H., & Glover, T. W. (2000) · The American Journal of Human Genetics · doi:10.1086/316915 · Cited by 611
Petrova, T. V., Karpanen, T., Norrmén, C., Mellor, R., Tamakoshi, T., Finegold, D., Ferrell, R., Kerjaschki, D., Mortimer, P., Ylä-Herttuala, S., et al. (2004) · Nature Medicine · doi:10.1038/nm1094 · Cited by 592
Cited by
The lymphatic vasculature in disease
Alitalo, K. (2011) · Nature Medicine · doi:10.1038/nm.2545 · Cited by 962
Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid
Ahn, J. H., Cho, H., Kim, J.-H., Kim, S. H., Ham, J.-S., Park, I., Suh, S. H., Hong, S. P., Song, J.-H., Hong, Y.-K., et al. (2019) · Nature · doi:10.1038/s41586-019-1419-5 · Cited by 811
Vascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653
Self-citationMechanisms of ephrin–Eph signalling in development, physiology and disease
Kania, A., & Klein, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.16 · Cited by 643
Sabine, A., Agalarov, Y., Maby-El Hajjami, H., Jaquet, M., Hägerling, R., Pollmann, C., Bebber, D., Pfenniger, A., Miura, N., Dormond, O., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.12.020 · Cited by 411
Self-citationFGF-dependent metabolic control of vascular development
Yu, P., Wilhelm, K., Dubrac, A., Tung, J. K., Alves, T. C., Fang, J. S., Xie, Y., Zhu, J., Chen, Z., De Smet, F., et al. (2017) · Nature · doi:10.1038/nature22322 · Cited by 366
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S. P., & Murfee, W. L. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c180015 · Cited by 341
The role of fatty acid β-oxidation in lymphangiogenesis
Wong, B. W., Wang, X., Zecchin, A., Thienpont, B., Cornelissen, I., Kalucka, J., García-Caballero, M., Missiaen, R., Huang, H., Brüning, U., et al. (2017) · Nature · doi:10.1038/nature21028 · Cited by 336
Lymphatic System in Cardiovascular Medicine
Aspelund, A., Robciuc, M. R., Karaman, S., Makinen, T., & Alitalo, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306544 · Cited by 321
Self-citationKazenwadel, J., Secker, G. A., Liu, Y. J., Rosenfeld, J. A., Wildin, R. S., Cuellar-Rodriguez, J., Hsu, A. P., Dyack, S., Fernandez, C. V., Chong, C.-E., et al. (2012) · Blood · doi:10.1182/blood-2011-08-374363 · Cited by 279
Lacteal junction zippering protects against diet-induced obesity
Zhang, F., Zarkada, G., Han, J., Li, J., Dubrac, A., Ola, R., Genet, G., Boyé, K., Michon, P., Künzel, S. E., et al. (2018) · Science · doi:10.1126/science.aap9331 · Cited by 237
Lymphatic Malformations: Genetics, Mechanisms and Therapeutic Strategies
Mäkinen, T., Boon, L. M., Vikkula, M., & Alitalo, K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318142 · Cited by 235
Intestinal lymphatic vasculature: structure, mechanisms and functions
Bernier-Latmani, J., & Petrova, T. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.79 · Cited by 219
Frye, M., Taddei, A., Dierkes, C., Martinez-Corral, I., Fielden, M., Ortsäter, H., Kazenwadel, J., Calado, D. P., Ostergaard, P., Salminen, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03959-6 · Cited by 169
Self-citationChoi, D., Park, E., Jung, E., Cha, B., Lee, S., Yu, J., Kim, P. M., Lee, S., Hong, Y. J., Koh, C. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125068 · Cited by 176
“Control pups (CTR) harbor Prox1-tdTomato and Prox1-CreERT2, but lack the Piezo1fl/fl allele, while lymphatic Piezo1-KO pups (Piezo1ΔLEC) have all Prox1-tdTomato, Prox1-CreERT2, and Piezo1fl/fl. Tamoxifen (75 mg/kg) was s.c. injected into pups at P1, and tissues were harvested and analyzed at P7.”
BackgroundMethodInfluentialRapid Modulation of Axon Initial Segment Length Influences Repetitive Spike Firing
Evans, M. D., Dumitrescu, A. S., Kruijssen, D. L. H., Taylor, S. E., & Grubb, M. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.066 · Cited by 159
“However, when we used an alternative, genetic method of DGC identification that does not rely on the stable presence of prox1 protein—cultures from Prox1CreER mice (Bazigou et al., 2011) treated with tamoxifen for 24 hr and infected with AAV-Flex-eGFP—we again observed 5 mm AIS shortening after 3-hr depolarization (10…”
MethodInfluentialVandael, D., Borges-Merjane, C., Zhang, X., & Jonas, P. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.013 · Cited by 114
“REAGENT or RESOURCE SOURCE IDENTIFIER Mowiol 4-88 Carl Roth Cat # 713.2 Cytochalasin D Tocris Cat # 1233 Latrunculin B Tocris Cat # 3974/1 H-89 dihydrochloride Tocris Cat # 2910/10 Tetrodotoxin citrate Tocris Cat # 1069/1 Tetraethylammonium chloride Sigma-Aldrich Cat # T2265 Cesium chloride Sigma-Aldrich Cat # C3011-2…”
MethodInfluentialLymphatic PD-L1 expression restricts tumor-specific CD8+ T-cell responses
Cousin, N., Cap, S., Dihr, M., Tacconi, C., Detmar, M., & Dieterich, L. C. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0633 · Cited by 95
“org Cancer Res; 81(15) August 1, 2021 4137”
BackgroundMethodInfluentialRASA1 regulates the function of lymphatic vessel valves in mice
Lapinski, P. E., Lubeck, B. A., Chen, D., Doosti, A., Zawieja, S. D., Davis, M. J., & King, P. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89607 · Cited by 71
Borges-Merjane, C., Kim, O., & Jonas, P. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.022 · Cited by 60
Vandael, D., Okamoto, Y., Borges-Merjane, C., Vargas-Barroso, V., Suter, B. A., & Jonas, P. (2021) · Nature Protocols · doi:10.1038/s41596-021-00526-0 · Cited by 28
Mechanosensitive mTORC1 signaling maintains lymphatic valves
Saygili Demir, C., Sabine, A., Gong, M., Dormond, O., & Petrova, T. V. (2023) · Journal of Cell Biology · doi:10.1083/jcb.202207049 · Cited by 24
Metadata
- Authors
- Bazigou, E., Lyons, O. T. A., Smith, A., Venn, G. E., Cope, C., Brown, N. A., & Makinen, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-08-01
- Volume
- 121
- Issue
- 8
- Pages
- 2984-2992
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2138019675
- Cited by
- 269
- References
- 31
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.